Ultralife Q1 2024 Adj EPS $0.21 Beats $0.10 Estimate, Sales $41.927M Beat $38.000M Estimate
Ultralife Q1 2024 Adj EPS $0.21 Beats $0.10 Estimate, Sales $41.927M Beat $38.000M Estimate
Ultralife 2024年第一季度調整後每股收益爲0.21美元，超過預期的0.10美元，銷售額爲419.27億美元，超過3,800萬美元的預期
Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.10 by 110 percent. The company reported quarterly sales of $41.927 million which beat the analyst consensus estimate of $38.000 million by 10.33 percent. This is a 31.37 percent increase over sales of $31.916 million the same period last year.
Ultralife（納斯達克股票代碼：ULBI）公佈的季度收益爲每股0.21美元，比分析師普遍預期的0.10美元高出110％。該公司公佈的季度銷售額爲4192.7萬美元，比分析師共識估計的380萬美元高出10.33％。這比去年同期的3191.6萬美元的銷售額增長了31.37％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。